Profile data is unavailable for this security.
About the company
Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of proprietary medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Its segments include cardiovascular and endoscopy. Its cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions, and original equipment manufacturer (OEM). Its endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures. Its product portfolio of medical devices and accessories used in lead management procedures for patients who need a pacemaker, or an implantable cardioverter-defibrillator lead removed or replaced. Its electrophysiology and cardiac rhythm management portfolio includes steerable and other specialty technologies.
- Revenue in USD (TTM)1.33bn
- Net income in USD120.04m
- Incorporated1987
- Employees6.95k
- LocationMerit Medical Systems Inc1600 West Merit Park WaySOUTH JORDAN 84095United StatesUSA
- Phone+1 (801) 253-1600
- Fax+1 (801) 253-1652
- Websitehttps://www.merit.com/
More ▼
Mergers & acquisitions
| Acquired company | MMSI:NSQ since announced | Transaction value |
|---|---|---|
| Cook Medical LLC-Lead Management Business | 5.47% | 210.00m |
Data delayed at least 15 minutes, as of Nov 21 2024 20:59 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Envista Holdings Corp | 2.50bn | -1.34bn | 3.68bn | 12.80k | -- | 1.20 | -- | 1.47 | -7.77 | -7.77 | 14.51 | 17.86 | 0.4106 | 4.21 | 6.19 | 195,570.30 | -21.93 | 1.94 | -25.27 | 2.34 | 54.20 | 57.65 | -53.42 | 5.29 | 1.77 | 3.13 | 0.3163 | 0.00 | -0.1012 | -2.04 | -142.10 | -- | -4.22 | -- |
| DENTSPLY SIRONA Inc | 3.90bn | -413.00m | 3.71bn | 15.00k | -- | 1.49 | -- | 0.9501 | -2.07 | -2.07 | 18.91 | 12.53 | 0.5641 | 2.94 | 5.91 | 260,000.00 | -5.93 | -1.14 | -7.41 | -1.32 | 52.18 | 53.65 | -10.51 | -2.51 | 0.8444 | 3.21 | 0.471 | -- | 1.10 | -0.1071 | 86.11 | -- | -4.54 | 9.86 |
| Guardant Health Inc | 692.26m | -512.41m | 3.83bn | 1.78k | -- | -- | -- | 5.53 | -4.24 | -4.24 | 5.70 | -0.488 | 0.415 | 3.68 | 7.81 | 389,126.50 | -30.72 | -22.26 | -35.19 | -24.59 | 60.31 | 64.62 | -74.02 | -97.07 | 5.85 | -8.04 | 1.06 | -- | 25.45 | 44.14 | 26.76 | -- | 0.2786 | -- |
| ICU Medical Inc | 2.34bn | -111.01m | 4.12bn | 14.00k | -- | 2.02 | 36.20 | 1.76 | -4.57 | -4.57 | 96.31 | 83.76 | 0.5391 | 2.16 | 13.94 | 167,149.80 | -2.56 | 1.46 | -2.90 | 1.65 | 32.87 | 34.11 | -4.74 | 2.23 | 1.03 | 0.5158 | 0.4382 | 0.00 | -0.9154 | 10.04 | 60.08 | -- | -1.45 | -- |
| Haemonetics Corporation | 1.36bn | 123.81m | 4.29bn | 3.66k | 35.48 | 4.90 | 18.39 | 3.15 | 2.41 | 2.41 | 26.48 | 17.44 | 0.6001 | 1.87 | 7.02 | 372,224.00 | 5.46 | 5.02 | 6.19 | 6.07 | 54.02 | 51.74 | 9.10 | 8.11 | 2.09 | 27.43 | 0.5823 | 0.00 | 12.01 | 6.23 | 1.87 | 16.40 | -11.04 | -- |
| Integer Holdings Corp | 1.68bn | 114.44m | 4.56bn | 10.50k | 41.89 | 2.81 | 20.60 | 2.71 | 3.24 | 3.22 | 47.87 | 48.33 | 0.5594 | 4.93 | 5.14 | 160,023.80 | 3.81 | 3.28 | 4.10 | 3.53 | 27.06 | 26.94 | 6.81 | 6.40 | 2.09 | 4.11 | 0.4028 | 0.00 | 16.03 | 5.62 | 38.71 | 9.33 | 21.71 | -- |
| Procept Biorobotics Corp | 199.84m | -100.06m | 5.11bn | 626.00 | -- | 20.42 | -- | 25.55 | -1.95 | -1.95 | 3.89 | 4.63 | 0.5026 | 1.83 | 3.86 | 319,238.00 | -25.16 | -- | -28.58 | -- | 57.39 | -- | -50.07 | -- | 5.07 | -- | 0.1758 | -- | 81.55 | -- | -21.51 | -- | -- | -- |
| Inspire Medical Systems Inc | 755.59m | 33.05m | 5.58bn | 1.01k | 171.11 | 8.01 | 146.81 | 7.38 | 1.09 | 1.09 | 25.15 | 23.25 | 1.05 | 2.46 | 9.37 | 747,372.90 | 4.60 | -11.27 | 5.12 | -12.60 | 84.77 | 84.47 | 4.37 | -13.57 | 6.94 | -- | 0.00 | -- | 53.19 | 65.32 | 52.87 | -- | 148.37 | -- |
| Stevanato Group SpA | 1.15bn | 120.12m | 5.94bn | 5.64k | 43.86 | 3.87 | 29.38 | 5.19 | 0.4473 | 0.4473 | 4.26 | 5.07 | 0.5284 | 2.75 | 2.66 | 203,340.60 | 5.54 | -- | 7.39 | -- | 29.20 | -- | 10.48 | -- | 1.21 | 48.53 | 0.2148 | -- | 10.34 | -- | 1.95 | -- | -- | -- |
| Lantheus Holdings Inc | 1.50bn | 427.61m | 6.07bn | 834.00 | 14.51 | 5.15 | 12.39 | 4.06 | 6.02 | 6.02 | 21.09 | 16.97 | 0.8383 | 8.28 | 5.09 | 1,794,723.00 | 23.95 | 6.69 | 32.76 | 7.73 | 64.78 | 57.56 | 28.57 | 9.02 | 1.56 | -- | 0.324 | 0.00 | 38.65 | 30.44 | 1,063.86 | 51.81 | 35.48 | -- |
| Merit Medical Systems Inc | 1.33bn | 120.04m | 6.12bn | 6.95k | 51.45 | 4.62 | 28.11 | 4.62 | 2.04 | 2.04 | 22.55 | 22.71 | 0.6334 | 2.29 | 7.41 | 190,772.80 | 5.73 | 2.45 | 6.32 | 2.77 | 46.83 | 44.50 | 9.05 | 3.91 | 3.82 | 31.88 | 0.3619 | 0.00 | 9.24 | 7.33 | 26.70 | 15.86 | -11.16 | -- |
| Glaukos Corp | 360.35m | -149.57m | 7.77bn | 907.00 | -- | 11.61 | -- | 21.55 | -2.96 | -2.96 | 7.06 | 12.13 | 0.3843 | 1.69 | 7.53 | 397,295.50 | -15.95 | -8.73 | -17.23 | -9.35 | 76.61 | 74.77 | -41.51 | -28.69 | 4.71 | -311.24 | 0.1591 | -- | 11.26 | 11.66 | -35.75 | -- | 14.44 | -- |
| Repligen Corp | 622.64m | -17.13m | 7.94bn | 1.78k | -- | 3.94 | 154.72 | 12.75 | -0.3079 | -0.3079 | 11.09 | 36.00 | 0.233 | 1.57 | 5.29 | 349,206.40 | -0.6411 | 4.38 | -0.7032 | 5.03 | 50.37 | 55.43 | -2.75 | 15.91 | 8.76 | -- | 0.2055 | 0.00 | -20.31 | 26.91 | -77.64 | 20.13 | 24.99 | -- |
| Bruker Corp | 3.24bn | 304.90m | 8.52bn | 9.71k | 27.11 | 4.72 | 18.05 | 2.63 | 2.07 | 2.07 | 21.89 | 11.92 | 0.6527 | 1.51 | 5.73 | 333,913.70 | 6.12 | 8.38 | 8.14 | 11.40 | 49.31 | 49.85 | 9.38 | 11.39 | 0.7085 | 26.83 | 0.5549 | 9.81 | 17.14 | 9.36 | 44.03 | 18.91 | 16.79 | 4.56 |
| Teleflex Inc | 3.03bn | 238.01m | 8.85bn | 14.50k | 37.80 | 1.98 | 17.53 | 2.93 | 5.04 | 5.03 | 64.01 | 96.50 | 0.404 | 2.11 | 6.76 | 208,677.50 | 3.18 | 5.86 | 3.46 | 6.42 | 55.99 | 54.43 | 7.87 | 14.62 | 1.39 | 6.61 | 0.2818 | 15.84 | 6.57 | 3.97 | -1.47 | 12.73 | 2.51 | 0.00 |
Data as of Nov 21 2024. Currency figures normalised to Merit Medical Systems Inc's reporting currency: US Dollar USD
47.59%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 30 Sep 2024 | 8.15m | 13.99% |
| The Vanguard Group, Inc.as of 30 Sep 2024 | 6.41m | 11.02% |
| Conestoga Capital Advisors LLCas of 30 Sep 2024 | 2.29m | 3.93% |
| SSgA Funds Management, Inc.as of 30 Sep 2024 | 2.23m | 3.83% |
| Fuller & Thaler Asset Management, Inc.as of 30 Sep 2024 | 1.60m | 2.74% |
| Macquarie Investment Management Business Trustas of 30 Sep 2024 | 1.59m | 2.73% |
| ArrowMark Colorado Holdings LLCas of 30 Sep 2024 | 1.46m | 2.50% |
| William Blair Investment Management LLCas of 30 Sep 2024 | 1.46m | 2.50% |
| Geode Capital Management LLCas of 30 Sep 2024 | 1.36m | 2.33% |
| Dimensional Fund Advisors LPas of 30 Sep 2024 | 1.17m | 2.01% |
More ▼
Data from 30 Sep 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
